[1] JOYCE J.B.C. VAN BEERS. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice[J]. Biochimie, 2013, 95 2: Pages 299-308. DOI:
10.1016/j.biochi.2012.09.029[2] SHINYA SAIJO . Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering[J]. Journal of Molecular Biology, 2016, 428 15: Pages 3058-3073. DOI:
10.1016/j.jmb.2016.06.018[3] RACHIDA NACHAT . Peptidylarginine Deiminase Isoforms 1–3 Are Expressed in the Epidermis and Involved in the Deimination of K1 and Filaggrin[J]. Journal of Investigative Dermatology, 2005, 124 2: Pages 384-393. DOI:
10.1111/j.0022-202x.2004.23568.x[4] AKEMI ISHIDA-YAMAMOTO. Decreased Deiminated Keratin K1 in Psoriatic Hyperproliferative Epidermis[J]. Journal of Investigative Dermatology, 2000, 114 4: Pages 701-705. DOI:
10.1046/j.1523-1747.2000.00936.x[5] AKEMI ISHIDA-YAMAMOTO . Sequential Reorganization of Cornified Cell Keratin Filaments Involving Filaggrin-Mediated Compaction and Keratin 1 Deimination[J]. Journal of Investigative Dermatology, 2002, 118 2: Pages 282-287. DOI:
10.1046/j.0022-202x.2001.01671.x[6] S. GONIAS M S T Hembrough. Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells.[J]. Frontiers in Bioscience-Landmark, 2001, 5 1: D1403-11. DOI:
10.2741/gonias[7] XIAOQIAN ZHANG. Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development[J]. Scientific Reports, 2016, 6 1. DOI:
10.1038/srep38727[8] HAO QIN . PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling[J]. Cancer letters, 2017, 409: Pages 30-41. DOI:
10.1016/j.canlet.2017.08.019